Pesticide exposure exacerbates α-synucleinopathy in an A53T transgenic mouse model

American Journal of Pathology

Volumn 170, Issue 2, 2007, Pages 658-666

  Norris, Erin H ^a   Uryu, Kunihiro ^a   Leight, Susan ^a   Giasson, Benoit I ^a   Trojanowski, John Q ^a   Lee, Virginia M Y ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; MANEB; MUTANT PROTEIN; PARAQUAT; PESTICIDE; FUNGICIDE; SNCA PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ALPHA SYNUCLEINOPATHY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CHEMICAL ANALYSIS; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE EXACERBATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYSOSOME; MITOCHONDRIAL MEMBRANE; MOTOR DYSFUNCTION; MOUSE; NERVE ENDING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; BRAIN; CELL INCLUSION; DRUG POTENTIATION; ENVIRONMENTAL EXPOSURE; GENETICS; METABOLISM; MISSENSE MUTATION; MITOCHONDRION; PARKINSON DISEASE; PATHOLOGY; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ALPHA-SYNUCLEIN; ANIMALS; BRAIN; DRUG SYNERGISM; ENVIRONMENTAL EXPOSURE; FUNGICIDES, INDUSTRIAL; HUMANS; INCLUSION BODIES; MANEB; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MUTATION, MISSENSE; PARAQUAT; PARKINSON DISEASE;

EID: 33947513592     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060359     Document Type: Article

References (52)

1. Norris EH, Giasson BI, Lee VMY: Alpha-synuclein: normal function and role in neurodegenerative diseases. Curr Top Dev Biol 2004, 60:17-54
2. Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC: Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 2005, 123:383-396
3. Forman MS, Lee VMY, Trojanowski JQ: Nosology of Parkinson's disease: looking for the way out of a quagmire. Neuron 2005, 47:479-482
4. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M: Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840
5. Beal MF: Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann NY Acad Sci 2003, 991:120-131
6. Moore DJ, West AB, Dawson VL, Dawson TM: Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 2005, 28:57-87
7. Barbeau PA, Cloutier T, Plasse L, Paris S: Environmental and genetic factors in the etiology of Parkinson's disease. Adv Neurol 1986, 45:299-306
8. Barbeau A, Roy M, Bernier G, Campanella G, Paris S: Ecogenetics of Parkinson's disease: prevalence and environmental aspects in rural areas. Can J Neurol Sci 1987, 14:36-41
9. Hertzman C, Weins M, Bowering D, Snow B, Calne D: Parkinson's disease: a case-control study of occupational and environmental risk factors. Am J Ind Med 1990, 17:349-355
10. Jimenez-Jimenez FJ, Mateo D, Gimenez-Roldman S: Exposure to well water and pesticides in Parkinson's disease: a case-control study in the Madrid area. Mov Disord 1992, 7:149-152
11. Tanner CM, Chen B, Wang W, Peng M, Liu Z, Liang X, Kao LC, Gilley DW, Goetz CG, Schoenberg BS: Environmental factors and Parkinson's disease: a case-control study in China. Neurology 1989, 39:660-664
12. Ferraz HB, Bertolucci PH, Pereira JS, Lima JG, Andrade LA: Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication. Neurology 1988, 38:550-553
13. Meco G, Bonifati V, Vanacore N, Fabrizio E: Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate). Scand J Work Environ Health 1994, 20:301-305
14. Ischiropoulos H, Beckman JS: Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 2003, 111:163-169
15. Manning-Bog AB, McCormack AL, Purisai MG, Bolin LM, Di Monte DA: Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. J Neurosci 2003, 23:3095-3099
16. Fredriksson A, Fredriksson M, Eriksson P: Neonatal exposure to paraquat or MPTP induces permanent changes in striatum dopamine and behavior in adult mice. Toxicol Appl Pharmacol 1993, 122:258-264
17. Liou HH, Chen RC, Tsai YF, Chen WP, Chang YC, Tsai MC: Effects of paraquat on the substantia nigra of the Wistar rats: neurochemical, histological, and behavioral studies. Toxicol Appl Pharmacol 1996, 137:34-41
18. Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA: The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem 2002, 277:1641-1644
19. McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, Cory-Slechta DA, Di Monte DA: Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 2002, 10:119-127
20. Uversky VN, Li J, Fink AL: Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease. FEBS Lett 2001, 500:105-108
21. Takahashi RN, Rogerio R, Zanin M: Maneb enhances MPTP neurotoxicity in mice. Res Commun Chem Pathol Pharmacol 1989, 66:167-170
22. Morato GS, Lemos T, Takahashi RN: Acute exposure to maneb alters some behavioral functions in the mouse. Neurotoxicol Teratol 1989, 11:421-425
23. Zhang J, Fitsanakis VA, Gu G, Jing D, Ao M, Amarnath V, Montine TJ: Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction. J Neurochem 2003, 84:336-346
24. Zhou Y, Shie FS, Piccardo P, Montine TJ, Zhang J: Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease. Neuroscience 2004, 128:281-291
25. Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, Cory-Slechta DA: The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J Neurosci 2000, 20:9207-9214
26. Thiruchelvam M, Richfield EK, Goodman BM, Baggs RB, Cory-Slechta DA: Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 2002, 23:621-633
27. Thiruchelvam M, McCormack A, Richfield EK, Baggs RB, Tank AW, Di Monte DA, Cory-Slechta DA: Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. Eur J Neurosci 2003, 18:589-600
28. Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VMY: Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron 2002, 34:521-533
29. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VMY, Trojanowski JQ, Iwatsubo T: Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998, 152:879-884
30. Duda JE, Giasson BI, Mabon ME, Lee VMY, Trojanowski JQ: Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 2002, 52:205-210
31. Uryu K, Giasson BI, Longhi L, Martinez D, Murray I, Conte V, Nakamura M, Saatman K, Talbot K, Horiguchi T, Mcintosh T, Lee VMY, Trojanowski JQ: Age-dependent synuclein pathology following traumatic brain injury in mice. Exp Neurol 2003, 184:214-224
32. Schmidt ML, Carden MJ, Lee VMY, Trojanowski JQ: Phosphate dependent and independent neurofilament epitopes in the axonal swellings of patients with motor neuron disease and controls. Lab Invest 1987, 56:282-294
33. Trojanowski JQ, Schuck T, Schmidt ML, Lee VMY: Distribution of tau proteins in the normal human central and peripheral nervous system. J Histochem Cytochem 1989, 37:209-215
34. Duda JE, Giasson BI, Gur TL, Montine TJ, Robertson D, Biaggioni I, Hurtig HI, Stern MB, Gollomp SM, Grossman M, Lee VMY, Trojanowski JQ: Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy. J Neuropathol Exp Neurol 2000, 59:830-841
35. Galvin JE, Uryu K, Lee VMY, Trojanowski JQ: Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci USA 1999, 96:13450-13455
36. Yazdani U, German DC, Liang CL, Manzino L, Sonsalla PK, Zeevalk GD: Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4- phenylpyridinium (MPP(+)). Exp Neurol 2006, 200: 172-183
37. Giasson BI, Uryu K, Trojanowski JQ, Lee VMY: Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem 1999, 274:7619-7622
38. Hattori N, Tanaka M, Ozawa T, Mizuno Y: Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann Neurol 1991, 30:563-571
39. Janetzky B, Hauck S, Youdim MB, Riederer P, Jellinger K, Pantucek F, Zochling R, Boissl KW, Reichmann H: Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci Lett 1994, 169:126-128
40. Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AH, Marsden CD: Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 1992, 115:333-342
41. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD: Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990, 54:823-827
42. Bindoff LA, Birch-Machin M, Cartlidge NE, Parker Jr WD, Turnbull DM: Mitochondrial function in Parkinson's disease. Lancet 1989, 2:49
43. Norris EH, Giasson BI: Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders. Antioxid Redox Signal 2005, 7:672-684
44. Fornai F, Schluter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, Lazzeri G, Busceti CL, Pontarelli F, Battaglia G, Pellegrini A, Nicoletti F, Ruggieri S, Paparelli A, Sudhof TC: Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci USA 2005, 102:3413-3418
45. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT: Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000, 3:1301-1306
46. Betarbet R, Canet-Aviles RM, Sherer TB, Mastroberardino PG, McLendon C, Kim JH, Lund S, Na HM, Taylor G, Bence NF, Kopito R, Seo BB, Yagi T, Yagi A, Klinefelter G, Cookson MR, Greenamyre JT: Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system. Neurobiol Dis 2006, 22:404-420
47. Sherer TB, Kim JH, Betarbet R, Greenamyre JT: Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp Neurol 2003, 179:9-16
48. Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT: Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci 2003, 23:10756-10764
49. Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M, Wong J, Takenouchi T, Hashimoto M, Masliah E: Alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 2000, 157:401-410
50. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D: Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 2004, 305:1292-1295
51. Conway KA, Harper JD, Lansbury PT: Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med 1998, 4:1318-1320
52. Serpen LC, Berriman J, Jakes R, Goedert M, Crowther RA: Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc Natl Acad Sci USA 2000, 97:4897-4902